A Dependable Solution for Each Patient's Unique Need
RELEXXII is available in seven strengths to optimize treatment to the lowest effective dose for symptom management.
Not actual patients. For illustrative purposes only.
Joey
Diagnosis: ADHD
Joey is newly diagnosed with ADHD and his provider started him on 18 mg of once-daily RELEXXII. With seven dosing options, and the flexibility to titrate up and down in 9 mg increments, Joey and his provider appreciate that RELEXXII can support him throughout his treatment journey.
Isabella
Diagnosis: ADHD
Isabella is currently taking 36 mg of methylphenidate. Based on recent symptoms, her provider needs to titrate her dose, but does not want to move up to 54 mg. In this case, the once-daily RELEXXII “in-between” strength of 45 mg provides a better option to titrate Isabella more gradually.
Josh
Diagnosis: ADHD
Josh is concerned about receiving tablets that vary in shape, size, and color from fill-to-fill. Josh’s provider heard his concern and prescribed once-daily RELEXXII as DAW 1. Josh is pleased to now have an expected, branded product he can reliably fill at the pharmacy.
*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. Offer effective 04/2024. Alora Pharmaceuticals, LLC reserves the right to rescind, revoke, or amend this offer without notice. For full terms and conditions, click here.
All individuals depicted are models used for illustrative purposes only.